Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 57

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

New perspectives on the role of SERCA2's Ca2+ affinity in cardiac function

Vangheluwe, P., Sipido, K.R., Raeymaekers, L., Wuytack, F. · 2006 · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.bbamcr.2006.08.025

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Research works printed but not linked: 125

  1. Schaub, 2006, Integration of calcium with the signaling network in cardiac myocytes, J. Mol. Cell. Cardiol., 41, 183, 10.1016/j.yjmcc.2006.04.005 · DOI
  2. Ringer, 1883, A further contribution regarding the influence of the different constituents of the blood on the contraction of the heart, J. Physiol., 4, 29, 10.1113/jphysiol.1883.sp000120 · DOI · Paper page
  3. Bers, 2002, Cardiac excitation–contraction coupling, Nature, 415, 198, 10.1038/415198a · DOI · Paper page
  4. Li, 1998, Cardiac myocyte calcium transport in phospholamban knockout mouse: relaxation and endogenous CaMKII effects, Am. J. Physiol., 274, H1335
  5. Periasamy, 2001, SERCA pump level is a critical determinant of Ca2+ homeostasis and cardiac contractility, J. Mol. Cell. Cardiol., 33, 1053, 10.1006/jmcc.2001.1366 · DOI · Paper page
  6. Campbell, 1991, Nucleotide sequences of avian cardiac and brain SR/ER Ca2+-ATPases and functional comparisons with fast twitch Ca2+-ATPase. Calcium affinities and inhibitor effects, J. Biol. Chem., 266, 16050, 10.1016/S0021-9258(18)98514-5 · DOI
  7. Lytton, 1992, Functional comparisons between isoforms of the sarcoplasmic or endoplasmic reticulum family of calcium pumps, J. Biol. Chem., 267, 14483, 10.1016/S0021-9258(19)49738-X · DOI · Paper page
  8. Verboomen, 1992, Functional difference between SERCA2a and SERCA2b Ca2+ pumps and their modulation by phospholamban, Biochem. J., 286, 591, 10.1042/bj2860591 · DOI
  9. Verboomen, 1994, The functional importance of the extreme C-terminal tail in the gene 2 organellar Ca2+-transport ATPase (SERCA2a/b), Biochem. J., 303, 979, 10.1042/bj3030979 · doi:10.1042/bj3030979
  10. Dode, 2003, Dissection of the functional differences between sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA) 1 and 2 isoforms and characterization of Darier disease (SERCA2) mutants by steady-state and transient kinetic analyses, J. Biol. Chem., 278, 47877, 10.1074/jbc.M306784200 · DOI
  11. Ver Heyen, 2001, Replacement of the muscle-specific sarcoplasmic reticulum Ca2+-ATPase isoform SERCA2a by the nonmuscle SERCA2b homologue causes mild concentric hypertrophy and impairs contraction–relaxation of the heart, Circ. Res., 89, 838, 10.1161/hh2101.098466 · DOI
  12. Vangheluwe, 2006, A SERCA2 pump with an increased Ca2+ affinity can lead to severe cardiac hypertrophy, stress intolerance and reduced life span, J. Mol. Cell. Cardiol., 41, 308, 10.1016/j.yjmcc.2006.05.014 · DOI
  13. Zarain-Herzberg, 1990, Characterization of rabbit cardiac sarco(endo)plasmic reticulum Ca2+-ATPase gene, J. Biol. Chem., 265, 4670, 10.1016/S0021-9258(19)39615-2 · DOI · Paper page
  14. Baba-Aissa, 1996, Distribution of the organellar Ca2+ transport ATPase SERCA2 isoforms in the cat brain, Brain Res., 743, 141, 10.1016/S0006-8993(96)01037-2 · doi:10.1016/s0006-8993(96)01037-2
  15. Vangheluwe, 2003, Ca2+ transport ATPase isoforms SERCA2a and SERCA2b are targeted to the same sites in the murine heart, Cell Calcium, 34, 457, 10.1016/S0143-4160(03)00126-X · doi:10.1016/s0143-4160(03)00126-x
  16. Lytton, 1989, Molecular cloning of the mammalian smooth muscle sarco(endo)plasmic reticulum Ca2+-ATPase, J. Biol. Chem., 264, 7059, 10.1016/S0021-9258(18)83540-2 · DOI
  17. Van den Bosch, 1994, Regulation of splicing is responsible for the expression of the muscle-specific 2a isoform of the sarco/endoplasmic-reticulum Ca2+-ATPase, Biochem. J., 302, 559, 10.1042/bj3020559 · DOI
  18. Escalante, 1993, Similar alternative splicing events generate two sarcoplasmic or endoplasmic reticulum Ca2+-ATPase isoforms in the crustacean Artemia franciscana and in vertebrates, J. Biol. Chem., 268, 14090, 10.1016/S0021-9258(19)85212-2 · doi:10.1016/s0021-9258(19)85212-2
  19. Zwaal, 2001, The sarco-endoplasmic reticulum Ca2+ ATPase is required for development and muscle function in Caenorhabditis elegans, J. Biol. Chem., 276, 43557, 10.1074/jbc.M104693200 · DOI
  20. Dode, 1996, cDNA cloning, expression and chromosomal localization of the human sarco/endoplasmic reticulum Ca2+-ATPase 3 gene, Biochem. J., 318, 689, 10.1042/bj3180689 · DOI
  21. Koss, 1995, Differential phospholamban gene expression in murine cardiac compartments. Molecular and physiological analyses, Circ. Res., 77, 342, 10.1161/01.RES.77.2.342 · DOI
  22. Kimura, 1998, Phospholamban domain Ib mutations influence functional interactions with the Ca2+-ATPase isoform of cardiac sarcoplasmic reticulum, J. Biol. Chem., 273, 14238, 10.1074/jbc.273.23.14238 · DOI · Paper page
  23. Cantilina, 1993, Comparative studies of cardiac and skeletal sarcoplasmic reticulum ATPases. Effect of a phospholamban antibody on enzyme activation by Ca2+, J. Biol. Chem., 268, 17018, 10.1016/S0021-9258(19)85295-X · DOI · Paper page
  24. Luo, 1994, Targeted ablation of the phospholamban gene is associated with markedly enhanced myocardial contractility and loss of beta-agonist stimulation, Circ. Res., 75, 401, 10.1161/01.RES.75.3.401 · DOI · Paper page
  25. Reddy, 2003, Defining the molecular components of calcium transport regulation in a reconstituted membrane system, Biochemistry, 42, 4585, 10.1021/bi026995a · DOI · Paper page
  26. Trieber, 2005, The effects of mutation on the regulatory properties of phospholamban in co-reconstituted membranes, Biochemistry, 44, 3289, 10.1021/bi047878d · DOI
  27. James, 1989, Nature and site of phospholamban regulation of the Ca2+ pump of sarcoplasmic reticulum, Nature, 342, 90, 10.1038/342090a0 · DOI · Paper page
  28. Simmerman, 1986, Sequence analysis of phospholamban. Identification of phosphorylation sites and two major structural domains, J. Biol. Chem., 261, 13333, 10.1016/S0021-9258(18)69309-3 · DOI · Paper page
  29. Wegener, 1989, Phospholamban phosphorylation in intact ventricles. Phosphorylation of serine 16 and threonine 17 in response to beta-adrenergic stimulation, J. Biol. Chem., 264, 11468, 10.1016/S0021-9258(18)60487-9 · DOI · Paper page
  30. MacDougall, 1991, Identification of the major protein phosphatases in mammalian cardiac muscle which dephosphorylate phospholamban, Eur. J. Biochem., 196, 725, 10.1111/j.1432-1033.1991.tb15871.x · DOI · Paper page
  31. Luo, 1996, Phospholamban gene dosage effects in the mammalian heart, Circ. Res., 78, 839, 10.1161/01.RES.78.5.839 · DOI
  32. Desai, 1999, Phospholamban deficiency does not compromise exercise capacity, Am. J. Physiol., 276, H1172
  33. Kadambi, 1996, Cardiac-specific overexpression of phospholamban alters calcium kinetics and resultant cardiomyocyte mechanics in transgenic mice, J. Clin. Invest., 97, 533, 10.1172/JCI118446 · DOI · Paper page
  34. Dash, 2001, Interactions between phospholamban and beta-adrenergic drive may lead to cardiomyopathy and early mortality, Circulation, 103, 889, 10.1161/01.CIR.103.6.889 · DOI
  35. Zvaritch, 2000, The transgenic expression of highly inhibitory monomeric forms of phospholamban in mouse heart impairs cardiac contractility, J. Biol. Chem., 275, 14985, 10.1074/jbc.275.20.14985 · DOI
  36. Haghighi, 2001, Superinhibition of sarcoplasmic reticulum function by phospholamban induces cardiac contractile failure, J. Biol. Chem., 276, 24145, 10.1074/jbc.M102403200 · DOI · Paper page
  37. Schmidt, 2002, Structural and functional implications of the phospholamban hinge domain: impaired SR Ca2+ uptake as a primary cause of heart failure, Cardiovasc. Res., 56, 248, 10.1016/S0008-6363(02)00541-2 · DOI
  38. Mattiazzi, 2005, Role of phospholamban phosphorylation on Thr17 in cardiac physiological and pathological conditions, Cardiovasc. Res., 68, 366, 10.1016/j.cardiores.2005.08.010 · DOI · Paper page
  39. Chu, 2000, A single site (Ser16) phosphorylation in phospholamban is sufficient in mediating its maximal cardiac responses to beta-agonists, J. Biol. Chem., 275, 38938, 10.1074/jbc.M004079200 · DOI · Paper page
  40. Vittone, 1990, cAMP and calcium-dependent mechanisms of phospholamban phosphorylation in intact hearts, Am. J. Physiol., 258, H318
  41. Mundina-Weilenmann, 1996, Immunodetection of phosphorylation sites gives new insights into the mechanisms underlying phospholamban phosphorylation in the intact heart, J. Biol. Chem., 271, 33561, 10.1074/jbc.271.52.33561 · DOI
  42. Said, 2002, The relative relevance of phosphorylation of the Thr17 residue of phospholamban is different at different levels of beta-adrenergic stimulation, Pflugers Arch., 444, 801, 10.1007/s00424-002-0885-y · doi:10.1007/s00424-002-0885-y
  43. Hagemann, 2000, Frequency-encoding Thr17 phospholamban phosphorylation is independent of Ser16 phosphorylation in cardiac myocytes, J. Biol. Chem., 275, 22532, 10.1074/jbc.C000253200 · DOI
  44. Zhao, 2004, Threonine-17 phosphorylation of phospholamban: a key determinant of frequency-dependent increase of cardiac contractility, J. Mol. Cell. Cardiol., 37, 607, 10.1016/j.yjmcc.2004.05.013 · DOI
  45. Bassani, 1995, CaMKII is responsible for activity-dependent acceleration of relaxation in rat ventricular myocytes, Am. J. Physiol., 268, H703
  46. DeSantiago, 2002, Frequency-dependent acceleration of relaxation in the heart depends on CaMKII, but not phospholamban, J. Mol. Cell. Cardiol., 34, 975, 10.1006/jmcc.2002.2034 · DOI · Paper page
  47. Valverde, 2005, Frequency-dependent acceleration of relaxation in mammalian heart: a property not relying on phospholamban and SERCA2a phosphorylation, J. Physiol., 562, 801, 10.1113/jphysiol.2004.075432 · DOI
  48. Odermatt, 1997, Characterization of the gene encoding human sarcolipin (SLN), a proteolipid associated with SERCA1: absence of structural mutations in five patients with Brody disease, Genomics, 45, 541, 10.1006/geno.1997.4967 · DOI · Paper page
  49. Asahi, 2002, Sarcolipin inhibits polymerization of phospholamban to induce superinhibition of sarco(endo)plasmic reticulum Ca2+-ATPases (SERCAs), J. Biol. Chem., 277, 26725, 10.1074/jbc.C200269200 · DOI
  50. Asahi, 2004, Cardiac-specific overexpression of sarcolipin inhibits sarco(endo)plasmic reticulum Ca2+ ATPase (SERCA2a) activity and impairs cardiac function in mice, Proc. Natl. Acad. Sci. U. S. A., 101, 9199, 10.1073/pnas.0402596101 · DOI
  51. Gramolini, 2004, Sarcolipin retention in the endoplasmic reticulum depends on its C-terminal RSYQY sequence and its interaction with sarco(endo)plasmic Ca2+-ATPases, Proc. Natl. Acad. Sci. U. S. A., 101, 16807, 10.1073/pnas.0407815101 · DOI
  52. Asahi, 2003, Sarcolipin regulates sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA) by binding to transmembrane helices alone or in association with phospholamban, Proc. Natl. Acad. Sci. U. S. A., 100, 5040, 10.1073/pnas.0330962100 · DOI · Paper page
  53. Hellstern, 2001, Sarcolipin, the shorter homologue of phospholamban, forms oligomeric structures in detergent micelles and in liposomes, J. Biol. Chem., 276, 30845, 10.1074/jbc.M102495200 · DOI
  54. Babu, 2005, Overexpression of sarcolipin decreases myocyte contractility and calcium transient, Cardiovasc. Res., 65, 177, 10.1016/j.cardiores.2004.08.012 · DOI
  55. Gayan-Ramirez, 2000, Corticosteroids decrease mRNA levels of SERCA pumps, whereas they increase sarcolipin mRNA in the rat diaphragm, J. Physiol., 524, 387, 10.1111/j.1469-7793.2000.t01-2-00387.x · DOI
  56. Minamisawa, 2003, Atrial chamber-specific expression of sarcolipin is regulated during development and hypertrophic remodeling, J. Biol. Chem., 278, 9570, 10.1074/jbc.M213132200 · DOI
  57. Vangheluwe, 2005, Sarcolipin and phospholamban mRNA and protein expression in cardiac and skeletal muscle of different species, Biochem. J., 389, 151, 10.1042/BJ20050068 · DOI
  58. Minajeva, 1997, Sarcoplasmic reticulum function in determining atrioventricular contractile differences in rat heart, Am. J. Physiol., 273, H2498
  59. Babu, 2006, Targeted overexpression of sarcolipin in the mouse heart decreases sarcoplasmic reticulum calcium transport and cardiac contractility, J. Biol. Chem., 281, 3972, 10.1074/jbc.M508998200 · DOI
  60. Gramolini, 2006, Cardiac-specific overexpression of sarcolipin in phospholamban null mice impairs myocyte function that is restored by phosphorylation, Proc. Natl. Acad. Sci. U. S. A., 103, 2446, 10.1073/pnas.0510883103 · DOI
  61. Freestone, 2000, Differential lusitropic responsiveness to beta-adrenergic stimulation in rat atrial and ventricular cardiac myocytes, Pflugers Arch., 441, 78, 10.1007/s004240000397 · doi:10.1007/s004240000397
  62. Kaasik, 2001, Decreased expression of phospholamban is not associated with lower beta-adrenergic activation in rat atria, Mol. Cell. Biochem., 223, 109, 10.1023/A:1017945810355 · doi:10.1023/a:1017945810355
  63. Odermatt, 1998, Sarcolipin regulates the activity of SERCA1, the fast-twitch skeletal muscle sarcoplasmic reticulum Ca2+-ATPase, J. Biol. Chem., 273, 12360, 10.1074/jbc.273.20.12360 · DOI · Paper page
  64. Morgan, 1990, Abnormal intracellular calcium handling, a major cause of systolic and diastolic dysfunction in ventricular myocardium from patients with heart failure, Circulation, 81, III21
  65. Beuckelmann, 1992, Intracellular calcium handling in isolated ventricular myocytes from patients with terminal heart failure, Circulation, 85, 1046, 10.1161/01.CIR.85.3.1046 · DOI · Paper page
  66. Hasenfuss, 1994, Relation between myocardial function and expression of sarcoplasmic reticulum Ca2+-ATPase in failing and nonfailing human myocardium, Circ. Res., 75, 434, 10.1161/01.RES.75.3.434 · DOI · Paper page
  67. Dipla, 1999, The sarcoplasmic reticulum and the Na+/Ca2+ exchanger both contribute to the Ca2+ transient of failing human ventricular myocytes, Circ. Res., 84, 435, 10.1161/01.RES.84.4.435 · DOI · Paper page
  68. Movsesian, 1994, Ca2+-transporting ATPase, phospholamban, and calsequestrin levels in nonfailing and failing human myocardium, Circulation, 90, 653, 10.1161/01.CIR.90.2.653 · DOI · Paper page
  69. Hasenfuss, 1997, Calcium handling proteins in the failing human heart, Basic Res. Cardiol., 92, 87, 10.1007/BF00794072 · DOI · Paper page
  70. Houser, 2000, Abnormalities of calcium cycling in the hypertrophied and failing heart, J. Mol. Cell. Cardiol., 32, 1595, 10.1006/jmcc.2000.1206 · DOI · Paper page
  71. Dash, 2001, Gender influences on sarcoplasmic reticulum Ca2+-handling in failing human myocardium, J. Mol. Cell. Cardiol., 33, 1345, 10.1006/jmcc.2001.1394 · DOI · Paper page
  72. Miyauchi, 2006, Comprehensive analysis of expression and function of fifty-one sarco(endo)plasmic reticulum Ca2+-ATPase mutants associated with darier disease, J. Biol. Chem., 10.1074/jbc.M601966200 · DOI
  73. Tavadia, 2001, Platelet and cardiac function in Darier's disease, Clin. Exp. Dermatol., 26, 696, 10.1046/j.1365-2230.2001.00921.x · DOI
  74. Mayosi, 2006, Heterozygous disruption of SERCA2a is not associated with impairment of cardiac performance in humans: implications for SERCA2a as a therapeutic target in heart failure, Heart, 92, 105, 10.1136/hrt.2004.051037 · DOI
  75. Periasamy, 1999, Impaired cardiac performance in heterozygous mice with a null mutation in the sarco(endo)plasmic reticulum Ca2+-ATPase isoform 2 (SERCA2) gene, J. Biol. Chem., 274, 2556, 10.1074/jbc.274.4.2556 · DOI · Paper page
  76. Ji, 2000, Disruption of a single copy of the SERCA2 gene results in altered Ca2+ homeostasis and cardiomyocyte function, J. Biol. Chem., 275, 38073, 10.1074/jbc.M004804200 · DOI
  77. Schwinger, 1999, Reduced Ca2+-sensitivity of SERCA2a in failing human myocardium due to reduced serin-16 phospholamban phosphorylation, J. Mol. Cell. Cardiol., 31, 479, 10.1006/jmcc.1998.0897 · DOI · Paper page
  78. Gupta, 2003, Cardiac SR-coupled PP1 activity and expression are increased and inhibitor 1 protein expression is decreased in failing hearts, Am. J. Physiol.: Heart Circ. Physiol., 285, H2373
  79. El-Armouche, 2004, Decreased protein and phosphorylation level of the protein phosphatase inhibitor-1 in failing human hearts, Cardiovasc. Res., 61, 87, 10.1016/j.cardiores.2003.11.005 · DOI
  80. Pathak, 2005, Enhancement of cardiac function and suppression of heart failure progression by inhibition of protein phosphatase 1, Circ. Res., 96, 756, 10.1161/01.RES.0000161256.85833.fa · DOI · Paper page
  81. Molkentin, 1998, A calcineurin-dependent transcriptional pathway for cardiac hypertrophy, Cell, 93, 215, 10.1016/S0092-8674(00)81573-1 · DOI · Paper page
  82. Braz, 2004, PKC-alpha regulates cardiac contractility and propensity toward heart failure, Nat. Med., 10, 248, 10.1038/nm1000 · DOI · Paper page
  83. Marx, 2000, PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts, Cell, 101, 365, 10.1016/S0092-8674(00)80847-8 · DOI · Paper page
  84. Lehnart, 2005, Phosphodiesterase 4D deficiency in the ryanodine–receptor complex promotes heart failure and arrhythmias, Cell, 123, 25, 10.1016/j.cell.2005.07.030 · DOI · Paper page
  85. Schmitt, 2003, Dilated cardiomyopathy and heart failure caused by a mutation in phospholamban, Science, 299, 1410, 10.1126/science.1081578 · DOI · Paper page
  86. Haghighi, 2006, A mutation in the human phospholamban gene, deleting arginine 14, results in lethal, hereditary cardiomyopathy, Proc. Natl. Acad. Sci. U. S. A., 103, 1388, 10.1073/pnas.0510519103 · DOI · Paper page
  87. Minamisawa, 2003, Mutation of the phospholamban promoter associated with hypertrophic cardiomyopathy, Biochem. Biophys. Res. Commun., 304, 1, 10.1016/S0006-291X(03)00526-6 · DOI
  88. del Monte, 2003, Targeting calcium cycling proteins in heart failure through gene transfer, J. Physiol., 546, 49, 10.1113/jphysiol.2002.026732 · DOI
  89. Hajjar, 1997, Physiological effects of adenoviral gene transfer of sarcoplasmic reticulum calcium ATPase in isolated rat myocytes, Circulation, 95, 423, 10.1161/01.CIR.95.2.423 · DOI · Paper page
  90. Davia, 2001, SERCA2a overexpression decreases the incidence of aftercontractions in adult rabbit ventricular myocytes, J. Mol. Cell. Cardiol., 33, 1005, 10.1006/jmcc.2001.1368 · DOI
  91. He, 1997, Overexpression of the rat sarcoplasmic reticulum Ca2+ ATPase gene in the heart of transgenic mice accelerates calcium transients and cardiac relaxation, J. Clin. Invest., 100, 380, 10.1172/JCI119544 · DOI · Paper page
  92. Baker, 1998, Targeted overexpression of the sarcoplasmic reticulum Ca2+-ATPase increases cardiac contractility in transgenic mouse hearts, Circ. Res., 83, 1205, 10.1161/01.RES.83.12.1205 · DOI · Paper page
  93. Ji, 1999, SERCA1a can functionally substitute for SERCA2a in the heart, Am. J. Physiol., 276, H89
  94. Muller, 2003, Transgenic rat hearts overexpressing SERCA2a show improved contractility under baseline conditions and pressure overload, Cardiovasc. Res., 59, 380, 10.1016/S0008-6363(03)00429-2 · DOI
  95. Maier, 2005, Increased SR Ca2+ cycling contributes to improved contractile performance in SERCA2a-overexpressing transgenic rats, Cardiovasc. Res., 67, 636, 10.1016/j.cardiores.2005.05.006 · DOI
  96. del Monte, 1999, Restoration of contractile function in isolated cardiomyocytes from failing human hearts by gene transfer of SERCA2a, Circulation, 100, 2308, 10.1161/01.CIR.100.23.2308 · DOI · Paper page
  97. Miyamoto, 2000, Adenoviral gene transfer of SERCA2a improves left-ventricular function in aortic-banded rats in transition to heart failure, Proc. Natl. Acad. Sci. U. S. A., 97, 793, 10.1073/pnas.97.2.793 · DOI · Paper page
  98. Vetter, 2002, Transgenic overexpression of the sarcoplasmic reticulum Ca2+ ATPase improves reticular Ca2+ handling in normal and diabetic rat hearts, FASEB J., 16, 1657, 10.1096/fj.01-1019fje · DOI
  99. Chen, 2004, Constitutive cardiac overexpression of sarcoplasmic/endoplasmic reticulum Ca2+-ATPase delays myocardial failure after myocardial infarction in rats at a cost of increased acute arrhythmias, Circulation, 109, 1898, 10.1161/01.CIR.0000124230.60028.42 · DOI
  100. Teucher, 2004, Excessive sarcoplasmic/endoplasmic reticulum Ca2+-ATPase expression causes increased sarcoplasmic reticulum Ca2+ uptake but decreases myocyte shortening, Circulation, 110, 3553, 10.1161/01.CIR.0000145161.48545.B3 · DOI
  101. He, 1999, Effects of mutant and antisense RNA of phospholamban on SR Ca2+-ATPase activity and cardiac myocyte contractility, Circulation, 100, 974, 10.1161/01.CIR.100.9.974 · DOI
  102. Ziolo, 2005, Adenoviral gene transfer of mutant phospholamban rescues contractile dysfunction in failing rabbit myocytes with relatively preserved SERCA function, Circ. Res., 96, 815, 10.1161/01.RES.0000163981.97262.3b · DOI
  103. Nakayama, 2003, Cardiac-specific overexpression of a high Ca2+ affinity mutant of SERCA2a attenuates in vivo pressure overload cardiac hypertrophy, FASEB J., 17, 61, 10.1096/fj.02-0474fje · doi:10.1096/fj.02-0474fje
  104. Dieterle, 2005, Gene transfer of a phospholamban-targeted antibody improves calcium handling and cardiac function in heart failure, Cardiovasc. Res., 67, 678, 10.1016/j.cardiores.2005.04.029 · DOI
  105. Eizema, 2000, Adenovirus-based phospholamban antisense expression as a novel approach to improve cardiac contractile dysfunction: comparison of a constitutive viral versus an endothelin-1-responsive cardiac promoter, Circulation, 101, 2193, 10.1161/01.CIR.101.18.2193 · DOI
  106. Meyer, 2004, A recombinant antibody increases cardiac contractility by mimicking phospholamban phosphorylation, FASEB J., 18, 1312, 10.1096/fj.03-1231fje · DOI
  107. del Monte, 2002, Targeting phospholamban by gene transfer in human heart failure, Circulation, 105, 904, 10.1161/hc0802.105564 · DOI · Paper page
  108. Minamisawa, 1999, Chronic phospholamban-sarcoplasmic reticulum calcium ATPase interaction is the critical calcium cycling defect in dilated cardiomyopathy, Cell, 99, 313, 10.1016/S0092-8674(00)81662-1 · DOI · Paper page
  109. Sato, 2001, Rescue of contractile parameters and myocyte hypertrophy in calsequestrin overexpressing myocardium by phospholamban ablation, J. Biol. Chem., 276, 9392, 10.1074/jbc.M006889200 · DOI
  110. Hoshijima, 2002, Chronic suppression of heart-failure progression by a pseudophosphorylated mutant of phospholamban via in vivo cardiac rAAV gene delivery, Nat. Med., 8, 864, 10.1038/nm739 · DOI · Paper page
  111. Iwanaga, 2004, Chronic phospholamban inhibition prevents progressive cardiac dysfunction and pathological remodeling after infarction in rats, J. Clin. Invest., 113, 727, 10.1172/JCI18716 · DOI · Paper page
  112. Delling, 2000, Re-evaluating sarcoplasmic reticulum function in heart failure, Nat. Med., 6, 942, 10.1038/79592 · doi:10.1038/79592
  113. Freeman, 2001, Alterations in cardiac adrenergic signaling and calcium cycling differentially affect the progression of cardiomyopathy, J. Clin. Invest., 107, 967, 10.1172/JCI12083 · DOI · Paper page
  114. Song, 2003, Rescue of cardiomyocyte dysfunction by phospholamban ablation does not prevent ventricular failure in genetic hypertrophy, J. Clin. Invest., 111, 859, 10.1172/JCI200316738 · DOI
  115. Antoons, 2003, Ca2+ uptake by the sarcoplasmic reticulum in ventricular myocytes of the SERCA2b/b mouse is impaired at higher Ca2+ loads only, Circ. Res., 92, 881, 10.1161/01.RES.0000069032.81501.98 · DOI
  116. Haghighi, 2003, Human phospholamban null results in lethal dilated cardiomyopathy revealing a critical difference between mouse and human, J. Clin. Invest., 111, 869, 10.1172/JCI17892 · DOI · Paper page
  117. Zhao, 2006, The presence of Lys27 instead of Asn27 in human phospholamban promotes sarcoplasmic reticulum Ca2+-ATPase superinhibition and cardiac remodeling, Circulation, 113, 995, 10.1161/CIRCULATIONAHA.105.583351 · DOI
  118. Arber, 1997, MLP-deficient mice exhibit a disruption of cardiac cytoarchitectural organization, dilated cardiomyopathy, and heart failure, Cell, 88, 393, 10.1016/S0092-8674(00)81878-4 · DOI · Paper page
  119. Antoons, 2006, Increased phospholamban phosphorylation limits the force-frequency response in the MLP−/− mouse with heart failure, J. Mol. Cell. Cardiol., 40, 350, 10.1016/j.yjmcc.2005.12.002 · DOI
  120. Hoit, 2006, Excitation–contraction coupling in the MLP knockout mouse, J. Mol. Cell. Cardiol., 40, 335, 10.1016/j.yjmcc.2006.01.004 · DOI
  121. Boateng, 1997, Inhibition of endogenous cardiac phosphatase activity and measurement of sarcoplasmic reticulum calcium uptake: a possible role of phospholamban phosphorylation in the hypertrophied myocardium, Biochem. Biophys. Res. Commun., 239, 701, 10.1006/bbrc.1997.7539 · doi:10.1006/bbrc.1997.7539
  122. Boknik, 2001, Enhanced protein phosphorylation in hypertensive hypertrophy, Cardiovasc. Res., 51, 717, 10.1016/S0008-6363(01)00346-7 · DOI
  123. Currie, 1999, Enhanced phosphorylation of phospholamban and downregulation of sarco/endoplasmic reticulum Ca2+ ATPase type 2 (SERCA 2) in cardiac sarcoplasmic reticulum from rabbits with heart failure, Cardiovasc. Res., 41, 135, 10.1016/S0008-6363(98)00241-7 · DOI
  124. Wu, 2004, An overview of stress echocardiography in the study of patients with dilated or hypertrophic cardiomyopathy, Echocardiography, 21, 467, 10.1111/j.0742-2822.2004.03083.x · doi:10.1111/j.0742-2822.2004.03083.x
  125. Wu, 2006, Local InsP3-dependent perinuclear Ca2+ signaling in cardiac myocyte excitation–transcription coupling, J. Clin. Invest., 116, 675, 10.1172/JCI27374 · DOI · Paper page

Cited by

See all 57

Metadata

Authors
Vangheluwe, P., Sipido, K. R., Raeymaekers, L., & Wuytack, F.
Venue
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
Publisher
Elsevier BV
Published
2006-11
Volume
1763
Issue
11
Pages
1216-1228
ISSN
0167-4889
Cited by
57
References
9
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: New perspectives on the role of SERCA2's Ca2+ affinity in cardiac function. https://app.cochat.ai/papers/10.1016/j.bbamcr.2006.08.025
The paper
Vangheluwe, P., Sipido, K. R., Raeymaekers, L., & Wuytack, F. (2006). New perspectives on the role of SERCA2's Ca2+ affinity in cardiac function. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. https://doi.org/10.1016/j.bbamcr.2006.08.025

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.